We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Research on Retinal Neovascularization of Diabetic Retinopathy

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01229540
First Posted: October 27, 2010
Last Update Posted: October 27, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Tianjin Medical University
October 26, 2010
October 27, 2010
October 27, 2010
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Clinical Research on Retinal Neovascularization of Diabetic Retinopathy
Not Provided
Retinal neovascularization of diabetic retinopathy might be associated with genetic risk factors and environmental risk factors.
Not Provided
Interventional
Not Provided
Not Provided
  • The Mechanism of Retinal Neovascularization of Diabetic
  • Retinopathy.
Genetic: genetic analyzer
No Intervention: Lifestyle counseling
Intervention: Genetic: genetic analyzer
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • T2DM was diagnosed according to the World Health Organization Expert Consultation Report 1999 and consisted of one of the following: fasting blood glucose (FBG) ≥7.0 mmol/L (≥126 mg/dL), blood glucose ≥11.1 mmol/L (≥200 mg/dL) 2 hours after an oral glucose tolerance test (OGTT); or a random blood glucose ≥11.1 mmol/L (≥200 mg/dL).
  • DR was clinically graded in accordance with the International Clinical Diabetic Retinopathy guidelines based on fundus fluorescence angiography.
  • All participants with PDR underwent a comprehensive dilated fundus examination to detect DR by indirect ophthalmoscopy and were diagnosed by fundus fluorescence angiography.

Exclusion Criteria:

  • Patients were excluded if they had acute complications of diabetes mellitus, type 1 diabetes mellitus, other types of diabetes, serious cardiovascular, hepatic, nephritic or other complications, other serious primary diseases or mental illness.
Sexes Eligible for Study: All
45 Years to 74 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
China
 
 
NCT01229540
08ZCGYSF01700
08ZCGYSF01700 ( Other Identifier: Tianjin Science and Technology Commission )
Not Provided
Not Provided
Not Provided
Not Provided
Tianjin Medical University
Not Provided
Not Provided
Tianjin Medical University
September 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP